SFG
LLY icon

Summit Financial Group’s Eli Lilly LLY Stock Holding History

Summit Financial Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$8.2M Buy
10,534
+35
+0.3% +$24.9K 2.91% 4
2023
Q4 		$6.12M Sell
10,499
-1,064
-9% -$621K 2.34% 8
2023
Q3 		$6.21M Sell
11,563
-2
-0% -$1.03K 2.61% 6
2023
Q2 		$5.42M Buy
11,565
+150
+1% +$62.9K 2.11% 8
2023
Q1 		$3.92M Sell
11,415
-2,500
-18% -$843K 1.49% 16
2022
Q4 		$5.09M Sell
13,915
-20
-0.1% -$7.09K 2.02% 10
2022
Q3 		$4.51M Sell
13,935
-740
-5% -$234K 1.87% 11
2022
Q2 		$4.76M Hold
14,675
– – 1.84% 10
2022
Q1 		$4.2M Sell
14,675
-150
-1% -$38.6K 1.42% 18
2021
Q4 		$4.09M Hold
14,825
– – 1.33% 20
2021
Q3 		$3.42M Hold
14,825
– – 1.24% 21
2021
Q2 		$3.4M Buy
14,825
+55
+0.4% +$11K 1.27% 22
2021
Q1 		$2.76M Sell
14,770
-168
-1% -$32.9K 1.15% 26
2020
Q4 		$2.52M Sell
14,938
-67
-0.4% -$10K 1.1% 25
2020
Q3 		$2.22M Hold
15,005
– – 1.1% 25
2020
Q2 		$2.46M Sell
15,005
-200
-1% -$30.7K 1.28% 20
2020
Q1 		$2.11M Hold
15,205
– – 1.26% 21
2019
Q4 		$2M Hold
15,205
– – 0.96% 30
2019
Q3 		$1.7M Sell
15,205
-2,600
-15% -$289K 0.86% 34
2019
Q2 		$1.97M Sell
17,805
-25
-0.1% -$2.94K 0.89% 31
2019
Q1 		$2.31M Hold
17,830
– – 1.81% 13
2018
Q4 		$2.06M Sell
17,830
-500
-3% -$55.9K 1.75% 16
2018
Q3 		$1.97M Hold
18,330
– – 1.47% 18
2018
Q2 		$1.56M Sell
18,330
-30
-0.2% -$2.46K 1.22% 26
2018
Q1 		$1.42M Buy
18,360
+1,480
+9% +$119K 1.11% 28
2017
Q4 		$1.43M Sell
16,880
-120
-0.7% -$10.2K 1.17% 25
2017
Q3 		$1.45M Sell
17,000
-50
-0.3% -$4.1K 1.21% 23
2017
Q2 		$1.4M Buy
+17,050
New +$1.39M 1.22% 22

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Summit Financial Group's LLY Position: Q1 2024 in Review

Summit Financial Group increased its Eli Lilly (LLY) stake by 0.33% in Q1 2024, buying an estimated $24.9K and bringing the position to 10,534 shares worth $8.2M. The position accounts for 2.91% of the portfolio, ranked #4.

Summit Financial Group first reported a position in LLY in Q2 2017 and has held it in 28 quarters since. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Summit Financial Group held 10,534 shares of Eli Lilly worth $8.2M as of Q1 2024.
  • Summit Financial Group bought 35 Eli Lilly shares in Q1 2024, an estimated $24.9K.
  • Eli Lilly made up 2.91% of Summit Financial Group's portfolio in Q1 2024, its #4 holding.
  • Summit Financial Group first reported a position in Eli Lilly in Q2 2017 and has held it in 28 quarters since.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.